Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 246,351 | 129,608 | 79,055 | 32,073 | 32,688 |
Marketable Securities | 167,804 | 216,196 | 153,619 | 132,963 | 144,473 |
Receivables | 200,362 | 105,900 | 83,994 | 22,661 | 35,023 |
Inventories | 67,297 | 86,451 | 68,846 | 63,689 | 59,033 |
TOTAL | $852,670 | $583,906 | $427,533 | $290,015 | $290,003 |
Non-Current Assets | |||||
PPE Net | 34,251 | 32,547 | 30,696 | 30,567 | 30,379 |
Intangibles | 2,171 | 2,225 | 2,197 | 2,297 | 2,196 |
Other Non-Current Assets | 30,619 | 29,231 | 29,693 | 30,393 | 30,817 |
TOTAL | $67,041 | $64,003 | $62,586 | $63,257 | $63,392 |
Total Assets | $919,711 | $647,909 | $490,119 | $353,272 | $353,395 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 3,596 | 12,079 | 3,154 | 3,312 | 5,273 |
Accrued Expenses | 91,845 | 29,878 | 18,973 | 21,904 | 20,131 |
Other current liabilities | 74,906 | 33,128 | 35,093 | 13,983 | 19,509 |
TOTAL | $528,935 | $204,642 | $109,422 | $77,411 | $66,625 |
Non-Current Liabilities | |||||
Long Term Debt | N/A | N/A | 179,889 | 179,811 | 179,733 |
Deferred Revenues | 358,588 | 129,557 | 52,202 | 38,212 | 21,712 |
Other Non-Current Liabilities | 255,231 | 252,937 | 36,696 | 37,357 | 37,753 |
TOTAL | $323,200 | $359,887 | $280,935 | $217,168 | $217,486 |
Total Liabilities | $852,135 | $564,529 | $390,357 | $294,579 | $284,111 |
Shareholders' Equity | |||||
Shares Outstanding, K | 119,952 | 114,760 | 114,588 | 113,256 | 110,173 |
Common Shares | 120 | 114 | 114 | 110 | 110 |
Retained earnings | -1,317,130 | -1,288,700 | -1,293,173 | -1,294,064 | -1,278,597 |
Other shareholders' equity | -1,528 | -713 | -1,126 | 273 | -1,022 |
TOTAL | $67,576 | $83,380 | $99,762 | $58,693 | $69,284 |
Total Liabilities And Equity | $919,711 | $647,909 | $490,119 | $353,272 | $353,395 |